Bivalirudin anticoagulation for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia

Canadian Journal of Anesthesia

Volumn 52, Issue 10, 2005, Pages 1093-1098

  Wasowicz, Marcin ^a   Vegas, Annette ^a   Borger, Michael A ^a   Harwood, Stephen ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; APROTININ; DOPAMINE; FENTANYL; FRESH FROZEN PLASMA; HEMOGLOBIN; HEPARIN; HIRULOG; ISOFLURANE; MIDAZOLAM; PANCURONIUM; PHENYLEPHRINE; PROPOFOL;

ABSCESS; ADULT; ANGIOCARDIOGRAPHY; AORTA ROOT; AORTA VALVE REPLACEMENT; ARTERY THROMBOSIS; ARTICLE; BACTERIAL ENDOCARDITIS; BLEEDING; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CASE REPORT; CLINICAL FEATURE; DRUG INFUSION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE TRANSFUSION; HEART VALVE PROSTHESIS; HEMOGLOBIN DETERMINATION; HEMOSTASIS; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; PREMEDICATION; PRIORITY JOURNAL; PROSTHESIS INFECTION; REOPERATION; SAPHENOUS VEIN GRAFT; STERNOTOMY; SURGICAL RISK; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

ABSCESS; ANTICOAGULANTS; CARDIOPULMONARY BYPASS; ECHOCARDIOGRAPHY; ENDOCARDITIS, BACTERIAL; FEMALE; HEPARIN; HIRUDINS; HUMANS; MIDDLE AGED; PEPTIDE FRAGMENTS; PROSTHESIS-RELATED INFECTIONS; RECOMBINANT PROTEINS; THROMBOCYTOPENIA;

EID: 32044444044     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03021611     Document Type: Article

References (24)

1. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention. The seventh AACP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126: 311S-37S.
2. Gurbuz AT, Elliot WG, Zia AA. Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines. Eur J Cardiothorac Surg 2005; 27: 138-49.
3. Sciulli TM, Mauro VF. Pharmacology and clinical use of bivalirudin. Ann Pharmacother 2002; 36: 1028-41.
4. Davis Z, Anderson R, Short D, Garber D, Valgiusti A. Favorable outcome with bivalirudin anticoagulation during cardiopulmonary bypass. Ann Thorac Surg 2003; 75: 264-5.
5. Bott JN, Reddy K, Krick S. Bivalrudin use in off-pump myocardial revascularization in patients with heparin-induced thrombocytopenia. Ann Thorac Surg 2003; 76: 273-5.
6. Koster A, Spiess B, Chew DP, et al. Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. Am J Cardiol 2004; 93: 356-9.
7. Matthai WH Jr. Thrombocytopenia in cardiovascular patients. Diagnosis and management. Chest 2005; 127: 46S-52S.
8. Magnani HN, Beijering RJ, Ten Cate JW, Chong BH. Orgaran anticoagulation for cardiopulmonary bypass in patients with heparin-induced thrombocytopenia. In: Pifarre R (Ed.). New Anticoagulants for the Cardiovascular Patient. Philadelphia: Hanley & Belfus Inc.; 1997: 487-500.
9. Zulys VJ, Teasdale SJ, Michel ER, et al. Ancrod (Arvin®) as an alternative to heparin anticoagulation for cardiopulmonary bypass. Anesthesiology 1989; 71: 870-7.
10. Koster A, Hansen R, Kuppe H, Hetzer R, Crystal GJ, Mertzlufft F. Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: a 1-year experience in 57 patients. J Cardiothorac Vasc Anesth 2000; 14: 243-8.
11. Edwards JT, Hamby JK, Worrall NK. Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient. Ann Thorac Surg 2003; 75: 1622-4.
12. Nuttall GA, Oliver WC Jr, Santrach PJ, et al. Patients with a history of type II heparin-induced thrombocytopenia with thrombosis requiring cardiac surgery with cardiopulmonary bypass: a prospective observational case series. Anesth Analg 2003; 96: 344-50.
13. Malherbe S, Tsui BC, Stobart K, Koller J. Argatroban as anticoagulant in cardiopulmonary bypass in an infant and attempted reversal with recombinant activated factor VII. Anesthesiology 2004; 100: 443-5.
14. Cannon MA, Butterworth J, Riley RD, Hyland JM. Failure of argatroban anticoagulation during off-pump coronary artery bypass surgery. Ann Thorac Surg 2004; 77: 711-3.
15. Clayton SB, Acsell JR, Crumbley III AJ, Shackelford AG, Uber WE. Cardiopulmonary bypass with bivalirudin in type II heparin-induced thrombocytopenia. Ann Thorac Surg 2004; 78: 2167-9.
16. Stratmann G, deSilva AM, Tseng EE, et al. Reversal of direct thrombin inhibition after cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia. Anesth Analg 2004; 98: 1635-9.
17. Welsby IJ, Stafford-Smith M. Monitoring direct thrombin inhibitors: time for standardization (Letter). Anesthesiology 2004; 101: 1048-9.
18. Klenner AF, Lubenow N, Raschke R, Greinacher A. Heparin-induced thrombocytopenia in children: 12 new cases and review of the literature. Thromb Haemost 2004; 91: 719-24.
19. Merry AF, Raudkivi PJ, Middleton NG, et al. Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery. Ann Thorac Surg 2004; 77: 925-31.
20. Koster A, Chew D, Grundel M, Bauer M, Kuppe H, Spiess BD. Bivalirudin monitored with ecarin clotting time for anticoagulation during cardiopulmonary bypass. Anesth Analg 2003; 96: 383-6.
21. Lange U, Nowak G, Bucha E. Ecarin chromogenic assay - a new method for quantitative determination of direct thrombin inhibitors like hirudin. Pathophysiol Haemost Thromb 2003; 33: 184-91.
22. Koster A, Despotis G, Gruendel M, et al. The plasma supplemented modified activated clotting time for monitoring of heparinization during cardiopulmonary bypass: a pilot investigation. Anesth Analg 2002; 95: 26-30.
23. Jabr K, Johnson JH, McDonald MH, et al. Plasma modified ACT can be used to monitor bivalirudin (Angiomax®) anticoagulation for on-pump cardiopulmonary bypass surgery in a patient with heparin-induced thrombocytopenia. J Extra Corpor Technol 2004; 36: 174-7.
24. Despotis GJ, Hogue CW, Saleem R, et al. The relationship between hirudin and activated clotting time: implications for patients with heparin-induced thrombocytopenia undergoing cardiac surgery. Anesth Analg 2001; 93: 28-32.